Osteosarcoma shows a strong association between ALT positivity and poor outcomes, independent of tumor stage, metastasis status, or treatment modality, with patients typically experiencing reduced progression-free and overall survival compared to their ALT-negative counterparts. Here, GPT is linked to osteosarcoma.